Mirati Therapeutics, Inc.

Tower Research Capital LLC (TRC)

Report date

12/31/2023

Quarter

2023 Q4

Filed

2/13/2024

Shares

2,387

Value ($000)

140

Weight

0.0%

2013 Q4 - 2023 Q4 (19 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q4	2/13/2024	140	0.0%	2,387	12/31/2023
2023 Q3	11/14/2023	65	0.0%	1,492	9/30/2023
2023 Q2	8/14/2023	534	0.0%	14,770	6/30/2023
2023 Q1	5/9/2023	148	0.0%	3,989	3/31/2023
2022 Q4	2/10/2023	529	0.0%	11,682	12/31/2022
2022 Q3	11/10/2022	424	0.0%	6,075	9/30/2022
2022 Q2	8/15/2022	994	0.0%	14,796	6/30/2022
2022 Q1	5/12/2022	736	0.0%	8,950	3/31/2022
2021 Q4	2/14/2022	293	0.0%	1,996	12/31/2021
2021 Q3	11/15/2021	219	0.0%	1,240	9/30/2021
2021 Q2	8/16/2021	675	0.0%	4,175	6/30/2021
2021 Q1	5/17/2021	396	0.0%	2,314	3/31/2021
2020 Q4	2/16/2021	670	0.0%	3,050	12/31/2020
2020 Q3	11/16/2020	554	0.0%	3,340	9/30/2020
2020 Q2	8/13/2020	272	0.0%	2,383	6/30/2020
2020 Q1	5/15/2020	2	0.0%	25	3/31/2020
2019 Q4	2/7/2020	82	0.0%	640	12/31/2019
2014 Q1	5/2/2014	52	0.0%	2,678	3/31/2014
2013 Q4	1/31/2014	31	0.0%	1,891	12/31/2013